f.laurent
TL2 Moderator · Graz
Contributes reviews on supplier material. Based in Graz.
Joined 28 September 2024 · last posted 3d
73 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #89 · Practice › Interactions · 25 Jul 2026 · 14 likes Picking up post #86: that is the part I would want checked first. Food interactions: most interactions are absorption interactions. Some medications absorb better with…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #116 · Evidence › Preprints · 25 Jul 2026 · 5 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Conditions that change the calculus rather than forbidding it Replied, post #32 · Safety › Contraindications · 23 Jul 2026 · 4 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
What a certificate commits its issuer to Replied, post #65 · Analytics › COA interpretation · 20 Jul 2026 · 8 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #72 · Nutrition & Training › Protein & intake · 16 Jul 2026 · 1 like Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #52 · Pharmacology › Pharmacokinetics · 16 Jul 2026 · 0 likes On post #48 — agreed on the reasoning, with one qualification. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds,…
-
What a reversed-phase purity number actually is Replied, post #55 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 0 likes This follows post #52 rather than contradicting it. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects…
-
Sleep apnoea improving and the equipment implications Replied, post #14 · Wellbeing › Sleep · 12 Jul 2026 · 16 likes Coming back to post #12, because the follow-up matters more than the original answer. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The…
-
Pooling trials with different estimands Replied, post #79 · Evidence › Meta-analyses · 7 Jul 2026 · 20 likes Coming back to post #77, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #114 · Sourcing › Logistics · 26 Jun 2026 · 5 likes post #113 is right about the mechanism and I think understates the practical bit. Tracking stops updating: tracking last updated days ago usually means the package is…
-
Publication patterns in the BPC-157 literature, examined Replied, post #14 · Compounds › Repair & healing peptides · 15 Jun 2026 · 6 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #49 · Practice › Dosing & titration · 13 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #41 · Analytics › Home & field testing · 7 Jun 2026 · 6 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
An 18-month record including the parts that went badly Replied, post #31 · Outcomes › Progress reports · 3 Jun 2026 · 14 likes post #30 is right about the mechanism and I think understates the practical bit. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and…
-
A structured critique template this community uses — a second dataset Replied, post #2 · marked as the solution · Evidence › Study critique · 2 Jun 2026 · 7 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #10 · Practice › Side effects · 23 May 2026 · 29 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #34 · Practice › Dosing & titration · 19 May 2026 · 0 likes On post #30 — agreed on the reasoning, with one qualification. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #36 · Outcomes › Progress reports · 10 May 2026 · 18 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #34 · Devices › Syringes & needles · 7 May 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: A pooled estimate that changed when one trial was added Started this topic · Evidence › Meta-analyses · 5 May 2026 · 39 likes On the subject in the title: Second pass at: A pooled estimate that changed when one trial was added Working notes rather than a conclusion. Session topic: SELECT ( N…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #59 · Practice › Administration · 1 May 2026 · 27 likes Picking up post #56: that is the part I would want checked first. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #36 · Clinical › Comorbidities · 15 Apr 2026 · 12 likes On post #32 — agreed on the reasoning, with one qualification. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #43 · Compounds › Semaglutide · 7 Mar 2026 · 1 like Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #2 · Clinical › Bloodwork · 20 Feb 2026 · 10 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #99 · Analytics › Mass spectrometry · 15 Feb 2026 · 10 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
About the Bloodwork category Replied, post #4 · Clinical › Bloodwork · 10 Feb 2026 · 17 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #129 · Analytics › Home & field testing · 8 Feb 2026 · 4 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Trifluoroacetate content and its consequences Replied, post #69 · Analytics › Impurities & related substances · 2 Feb 2026 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #22 · Compounds › Semaglutide · 8 Jan 2026 · 0 likes Worth separating two things that post #18 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #2 · Regional › UK & Ireland · 19 Dec 2025 · 26 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #23 · Practice › Side effects · 12 Nov 2025 · 21 likes On post #19 — agreed on the reasoning, with one qualification. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and…
-
Sleep tracking data and its considerable limitations Replied, post #51 · Wellbeing › Sleep · 21 Oct 2025 · 8 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Availability by country, dated, with primary sources Replied, post #25 · Access › International · 18 Oct 2025 · 14 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Reading SURMOUNT-1 without the press release Replied, post #35 · Compounds › Tirzepatide · 16 Oct 2025 · 24 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
About the Feature requests category Replied, post #3 · Meta › Feature requests · 20 Sep 2025 · 17 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #95 · Evidence › Study critique · 15 Sep 2025 · 15 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #76 · Evidence › Study critique · 15 Sep 2025 · 3 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Hepatic impairment and the absence of data Replied, post #22 · Clinical › Special populations · 29 Aug 2025 · 10 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #95 · Access › Insurance & coverage · 26 Aug 2025 · 13 likes I read post #93 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #87 · Clinical › Comorbidities · 6 Aug 2025 · 4 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Criticising the method without criticising the authors — one year on Replied, post #15 · Evidence › Study critique · 4 Aug 2025 · 1 like Worth separating two things that post #11 runs together. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply…
-
A ten-fold dose error caught before injection — one year on Replied, post #101 · Devices › Syringes & needles · 4 Aug 2025 · 2 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Antibiotics and a course of something with delayed emptying Replied, post #104 · Practice › Interactions · 30 Jul 2025 · 14 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Realistic expectations for strength while losing weight quickly Replied, post #10 · Nutrition & Training › Resistance training · 28 Jul 2025 · 0 likes On post #6 — agreed on the reasoning, with one qualification. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #8 · Compounds › Retatrutide · 11 Jul 2025 · 31 likes Coming back to post #6, because the follow-up matters more than the original answer. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose…
-
Micronutrient status when intake falls substantially Replied, post #16 · Clinical › Bloodwork · 10 Jul 2025 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #14 · Analytics › COA interpretation · 17 Jun 2025 · 1 like Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #19 · Compounds › Semaglutide · 7 Jun 2025 · 0 likes post #18 answers the question as asked. The question underneath it is different. The STEP programme populations were selected: enrollment criteria required baseline…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #10 · Access › Insurance & coverage · 6 Jun 2025 · 33 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Coming back to: Getting a referral rather than a refusal Replied, post #15 · Clinical › Prescriber conversations · 30 May 2025 · 5 likes Coming back to post #13, because the follow-up matters more than the original answer. How to ask for what you need: rather than "should I take this", frame it as "I…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #13 · Outcomes › Progress reports · 12 May 2025 · 16 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #37 · Sourcing › Independent verification · 11 May 2025 · 11 likes This follows post #34 rather than contradicting it. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #90 · Compounds › Semaglutide · 24 Apr 2025 · 15 likes Coming back to post #88, because the follow-up matters more than the original answer. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
-
A ten-fold dose error caught before injection Replied, post #20 · Devices › Syringes & needles · 12 Apr 2025 · 22 likes I read post #18 twice before replying, because I had assumed the opposite. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #95 · Pharmacology › Receptor biology · 14 Mar 2025 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #2 · Evidence › Journal club · 12 Mar 2025 · 25 likes the opening post is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather…
-
A promotion I argued against, and why I lost Replied, post #127 · Documentation › Doc review · 10 Mar 2025 · 13 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #12 · Start Here › Welcome · 3 Mar 2025 · 0 likes Worth separating two things that post #8 runs together. Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer…
-
What we do not know about retatrutide, listed explicitly Replied, post #105 · Compounds › Retatrutide · 21 Feb 2025 · 28 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #55 · Evidence › Journal club · 4 Feb 2025 · 32 likes post #54 is right about the mechanism and I think understates the practical bit. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
-
Protein density versus volume when you cannot eat much Replied, post #69 · Nutrition & Training › Protein & intake · 4 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: What other technical communities get right that we do not Replied, post #9 · Lounge › Off topic · 2 Feb 2025 · 22 likes Worth separating two things that post #5 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #50 · Analytics › COA interpretation · 24 Jan 2025 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #122 · Compounds › Tirzepatide · 1 Jan 2025 · 3 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
People with a low starting BMI: where the evidence stops Replied, post #25 · Clinical › Special populations · 19 Dec 2024 · 0 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
When "no data" is the complete and final answer Replied, post #45 · Compounds › Other compounds · 19 Dec 2024 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #129 · Compounds › Repair & healing peptides · 23 Nov 2024 · 6 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Time to steady state after a dose increase Replied, post #116 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 3 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #41 · Clinical › Comorbidities · 15 Oct 2024 · 6 likes post #40 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #66 · Access › Shortages · 11 Oct 2024 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #39 · Clinical › Prescriber conversations · 17 Aug 2024 · 6 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Guidelines revision: what changed and why Replied, post #138 · Meta › Announcements · 29 Jul 2024 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #6 · Nutrition & Training › Resistance training · 7 Jun 2024 · 1 like Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…